These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 19472574)

  • 21. Outcomes of Alzheimer's disease treatment: the Italian CRONOS project.
    Bianchetti A; Padovani A; Trabucchi M
    Int J Geriatr Psychiatry; 2003 Jan; 18(1):87-8. PubMed ID: 12497562
    [No Abstract]   [Full Text] [Related]  

  • 22. The treatment of Alzheimer's disease: the approach from a clinical specialist in the trenches.
    Hake AM
    Semin Neurol; 2002 Mar; 22(1):71-4. PubMed ID: 12170395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Alzheimer patients treated with anti-dementia drugs despite unanswered questions].
    Padberg F; Hampel H; Möller HJ
    Fortschr Med Orig; 2001 Nov; 119(3-4):141-3. PubMed ID: 11789127
    [No Abstract]   [Full Text] [Related]  

  • 24. Cholinesterase inhibitors: relating pharmacological properties to clinical profiles: Introduction.
    Farlow MR
    Int J Clin Pract Suppl; 2002 Jun; (127):1-5. PubMed ID: 12139364
    [No Abstract]   [Full Text] [Related]  

  • 25. Tense prescriptions? Alzheimer medications and the anthropology of uncertainty.
    Leibing A
    Transcult Psychiatry; 2009 Mar; 46(1):180-206. PubMed ID: 19293285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galantamine improves gait performance in patients with Alzheimer's disease.
    Assal F; Allali G; Kressig RW; Herrmann FR; Beauchet O
    J Am Geriatr Soc; 2008 May; 56(5):946-7. PubMed ID: 18454755
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative cardiovascular safety of dementia medications: a cross-national study.
    Fosbøl EL; Peterson ED; Holm E; Gislason GH; Zhang Y; Curtis LH; Køber L; Iwata I; Torp-Pedersen C; Setoguchi S
    J Am Geriatr Soc; 2012 Dec; 60(12):2283-9. PubMed ID: 23176182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Present trends in the development of drugs within the cholinesterase inhibitor group as therapeutic agents for Alzheimer's disease].
    Patocka J; Fusek J
    Cesk Psychiatr; 1992 Sep; 88(5):258-69. PubMed ID: 1451205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alcohol abuse in an elderly woman taking donepezil for Alzheimer disease.
    Marinho V; Laks J; Engelhardt E; Conn D
    J Clin Psychopharmacol; 2006 Dec; 26(6):683-5. PubMed ID: 17110839
    [No Abstract]   [Full Text] [Related]  

  • 31. [Complete atrioventricular block during galantamine therapy].
    Leentjens AF; Kragten JA
    Ned Tijdschr Geneeskd; 2006 Mar; 150(10):563-6. PubMed ID: 16566422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerance to tacrine, arterial hypotension and leuko-araiosis in Alzheimer's disease.
    Lebert F; Mouly C; Pasquier F
    Age Ageing; 1998 Sep; 27(5):654. PubMed ID: 12675108
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan.
    Nozawa M; Ichimiya Y; Nozawa E; Utumi Y; Sugiyama H; Murayama N; Iseki E; Arai H
    Psychogeriatrics; 2009 Jun; 9(2):50-5. PubMed ID: 19604325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between cholinesterase inhibitors and Pisa syndrome in a cohort of five French patients with Alzheimer's disease.
    Huvent-Grelle D; Roche J; Camus FE; Dewailly P; Puisieux F
    J Am Geriatr Soc; 2007 Sep; 55(9):1472-5. PubMed ID: 17767692
    [No Abstract]   [Full Text] [Related]  

  • 35. Thyroid function in patients with Alzheimer's disease treated with cholinesterase inhibitors.
    Kapaki E; Ilias I; Paraskevas GP; Theotoka I; Christakopoulou I
    Acta Neurobiol Exp (Wars); 2003; 63(4):389-92. PubMed ID: 15053263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study.
    Mohs RC; Shiovitz TM; Tariot PN; Porsteinsson AP; Baker KD; Feldman PD
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):752-9. PubMed ID: 19700948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Outpatient treatment of patients suffering from Alzheimer dementia. Two exploratory studies on the characteristics of therapy in medical practice].
    Haupt M; Rosenfeld S; Stoppe G
    MMW Fortschr Med; 2004 Aug; 146 Suppl 2():51-6. PubMed ID: 16739359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.
    Gallini A; Sommet A; Salandini AM; Veyssière P; Montastruc JL; Montastruc JL
    Mov Disord; 2007 Oct; 22(13):1980-1. PubMed ID: 17657810
    [No Abstract]   [Full Text] [Related]  

  • 39. [Dementia--treatment].
    Stoppe G; Stiens G; Staedt J
    Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1544-6; quiz 147-50. PubMed ID: 12854065
    [No Abstract]   [Full Text] [Related]  

  • 40. [Alzheimer's disease--treatment with and without drugs].
    Wolter DK
    MMW Fortschr Med; 2012 Apr; 154(7):85-7, 89-90. PubMed ID: 22558882
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.